Bahaa Fam

Through Greystone Partners, Bahaa serves as an advisor to corporations and the federal government. Bahaa counsels senior executives leading businesses in the areas of healthcare delivery, finance, national security and pharmaceutical development.  Bahaa typically advises the federal government on complex technical and operational issues at the Secretary and Sub-Cabinet level.  Bahaa also advises on research and development strategy as well as the selection and shaping of specific research and corporate investments.  For both corporate and government clients Bahaa has initiated and directed activities in the economic analysis of large scale health delivery and defense systems, machine learning for automation, specialized pharmaceutical development and delivery and operations optimization / management. Bahaa has also led efforts in disease propagation dynamics/modeling and epidemic course of action economics and optimization. 

Prior to forming Greystone Partners, Bahaa worked for Fidelity Investments for 14 years. At Fidelity, Bahaa was, most recently, Senior Vice President in and portfolio manager at Fidelity’s Institutional money management unit and a Venture Partner  with Fidelity‘s internal venture arm.  As venture partner, Bahaa led the B round investment in Accuri Cytometers.  Fidelity exited Accuri at a significant multiple of its investment within two years when Accuri was purchased by Becton Dickinson.  Bahaa also led the negotiations with the key supplier of TCT Medical and materially restructured the supply agreement prior to Fidelity’s investment in the firm.  That supplier later purchased TCT resulting in Fidelity’s exit at a significant multiple of its original investment within two years.  As a portfolio manager in Fidelity’s Institutional Investment’s institutional investment company, Bahaa actively managed $6 Billion in domestic growth equity assets for a variety of institutions.  Bahaa’s Institutional Large Cap Growth Portfolio was ranked as the top domestic large cap growth fund in the Callan US Institutional Universe on a 1 and 3-year basis in 2006. His Mid-Cap growth fund was featured in national publications after the fund achieved a three-year rate of return of 23.9% per annum.

Bahaa joined Fidelity in 1994 and was a senior quantitative equity analyst from 1994 to 1998. In this role, he designed stock selection models for the equity group and worked closely with Fidelity's equity managers on portfolio strategy, return analysis and stock selection. From 1998 through 2004, Bahaa served as Fidelity's Director of Quantitative Research where he led teams of analysts involved in the design of valuation, equity selection and asset allocation models and the development of strategic and tactical investment strategies. Bahaa materially redesigned the Fidelity Asset Manager™ fund complex in 1995 lifting the funds from bottom quartile performance prior to the restructuring to top decile performance in the years following.  Bahaa also served on Fidelity’s Asset Allocation Committee from 1997 to 2008. Immediately following the collapse of Long Term Capital, Bahaa’s models recommended that Fidelity funds purchase long term high yield debt which resulted in significant returns for Fidelity shareholders over the next 12 months. Bahaa also led  asset class research where he examined opportunities in nontraditional and complex assets for Fidelity’s senior leadership.

Prior to joining Fidelity in 1994, Bahaa was managing director and consulting scientist at the MITRE Corporation. While at MITRE, Bahaa directed efforts in the areas of image and signal processing, medical imaging, and mathematical economics. He also developed techniques and directed activities in the design of technology venture and research portfolios and technology investment strategy.  Bahaa created a number of novel algorithms for signal detection in radar and complex images, large scale network optimization and digital privacy. He has published academic papers in the areas of computer and communications security, image processing, computer architecture, digital mammography, parallel computing structures, and novel algorithms.

Bahaa has served on the Board of The Whiting School of Engineering at The Johns Hopkins University since 2008, the Advisory Board of Our Generation Speaks since 2018 (affiliated with Brandeis University and The Massachusetts Institute of Technology) as well as on the external advisory committee for Electrical and Computer Engineering at John Hopkins for almost two decades.  

Bahaa has a Bachelor of Science degree in electrical engineering and computer science and a Master of Science degree with a concentration in optimization theory and economic systems from The Johns Hopkins University.

Bahaa has also served on the Board of Directors for U.S. Genomics and Accuri Cytometers, Inc., the advisory board of the West Philadelphia EVX automotive X – Prize team, and the Board of Corporators of Winchester Hospital.